Replies to post #487709 on NorthWest Biotherapeutics Inc (NWBO)

[Fireman02360]

Should we expect an hostile take over shortly after the journal?

I had this very conversation with someone on this board, as it was a concern of mine. Does anyone know if Management put a "poison pill" in place to prevent such a thing? I would have been a proxy vote. Anavex Life Sciences did this about 3 years ago....... adding the extra warrant we would get for each share at a specified price, etc to offset a hostile maneuver/takeover from an outside company. Genius move on the part CEO Missling.

Does NW Bio have anything similar???

-Fireman

[extrooper]

I would love to see a hostile take over.

[IkeEsq]

I seriously doubt any of this is going to happen.

NWBO is a Biotech company. They do not have the resources or even interest in getting side-tracked filling frivolous lawsuits against AF and others. There is zero to be gained from such suits and compared to curing cancer, it is a total waste of time.

While the DoJ could bring civil or criminal cases, don't hold your breath. Expect an investigation about something like this to take many years and to eventually settle a long time from now. The DoJ is not going to time their case(s) based on when a journal article is published. That is beyond ridiculous.

Yeah, the journal certainly better cover a lot more about DC-Vax, that is the entire point of doing the journal.

A hostile takeover? Where do people come up with this stuff? Take a look at: their anti-takeover provisions and see if you still think that is a possibility. I'll give you a hint: "No."

Short squeeze? People have been talking about that for YEARS. You do understand that the shorts are well aware of what is coming, right? This isn't a secret. Don't worry about the shorts, they have protected themselves.